LAV of BPIFB4 gene was described to protect from age-related endothelial dysfunction (21,22) and atherosclerosis, 2 main age-related conditions, mainly by conferring subjects with a favorable maintenance of nitric oxide bioavailability and huge anti-inflammatory profile. This evidence concerns the gene BPIFB4 and endothelial dysfunction.